Efficacy of pirtobrutinib in BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Phase 1/2 BRUIN study results by prior BCL2-inhibitor therapy Meeting Abstract
| Authors: | Woyach, J. A.; Brown, J. R.; Ghia, P.; Roeker, L. E.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; Seymour, J.; Shah, N. N.; Ujjani, C.; Fahkri, B.; Coombs, C. C.; Flinn, I.; Patel, M. R.; Nasta, S. D.; Cohen, J. B.; Alencar, A. J.; Cheah, C. Y.; Ma, S.; Rhoades, J. M.; Jagadeesh, D.; Zinzani, P. L.; Osterborg, A.; Izutsu, K.; Tsai, D. E.; Abada, P.; Balbas, M.; Ruppert, A. S.; Li, J.; Jurczak, W.; Wierda, W. G.; Stilgenbauer, S. |
| Abstract Title: | Efficacy of pirtobrutinib in BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Phase 1/2 BRUIN study results by prior BCL2-inhibitor therapy |
| Meeting Title: | 36. Deutscher Krebskongress - Fortschritt gemeinsam gestalten |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 47 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Feb 21-24 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2024-02-01 |
| Start Page: | 118 |
| End Page: | 119 |
| Language: | English |
| ACCESSION: | WOS:001332646400283 |
| PROVIDER: | wos |
| DOI: | 10.1159/000535363 |
| Notes: | Meeting Abstract: 549 -- 'The 36th German Cancer Congress - Building Progress Together' -- Located in the section 'Hematooncology including Bone marrow transplantation, Lymphoma, Plasmocytoma' -- Source: Wos |
